Hypoglycemic Properties of Oxovanadium (IV) Coordination Compounds with Carboxymethyl-Carrageenan and Carboxymethyl-Chitosan in Alloxan-Induced Diabetic Mice

被引：12

作者：

Zhang, Hongyu ^{[2
]}

Yi, Yuetao ^{[1
]}

Feng, Dawei

Wang, Yipeng

Qin, Song ^{[1
]}

机构：

[1] Chinese Acad Sci, Yantai Inst Coastal Zone Res, Biol Resources Lab, Yantai 264003, Peoples R China

[2] Chinese Acad Sci, Grad Sch, Beijing 100049, Peoples R China

来源：

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE | 2011年 / 2011卷

关键词：

VANADYL SULFATE; INSULIN SENSITIVITY; BLOOD-GLUCOSE; IN-VIVO; COMPLEXES; OXIDATION; SYSTEM; RATS;

D O I：

10.1155/2011/691067

中图分类号：

R [医药、卫生];

学科分类号：

10 ;

摘要：

In order to avoid low absorption, incorporation, and undesirable side effects of inorganic oxovanadium compounds, the antidiabetic activities of organic oxovanadium (IV) compounds in alloxan-induced diabetic mice were investigated. Vanadyl carboxymethyl carrageenan (VOCCA) and vanadyl carboxymethyl chitosan (VOCCH) were synthesized and administrated through intragastric administration in different doses for 20 days in alloxan-induced diabetic mice. Glibenclamide was administrated as the positive control. Our results showed that low-dose group, middle-dose group, and high-dose group of VOCCA and VOCCH could significantly reduce the levels of blood glucose (P < 0.05) compared with untreated group, but not in normal mice. Besides, high-dose groups of VOCCA and VOCCH exhibited more significant hypoglycemic activities (P < 0.01). After treated with VOCCH, the oral glucose tolerance of high-dose group of VOCCH was improved compared with model control group (P < 0.05).

引用

页码：1 / 7

页数：7

共 33 条

[21] Structure-activity relationship of insulinomimetic vanadyl-picolinate complexes in view of their clinical use [J].

Sakurai, H ;

Yasui, H .

JOURNAL OF TRACE ELEMENTS IN EXPERIMENTAL MEDICINE, 2003, 16 (04) :269-280

[22] A new concept: The use of vanadium complexes in the treatment of diabetes mellitus [J].

Sakurai, H .

CHEMICAL RECORD, 2002, 2 (04) :237-248

[23] Antidiabetic vanadium(IV) and zinc(II) complexes [J].

Sakurai, H ;

Kojima, Y ;

Yoshikawa, Y ;

Kawabe, K ;

Yasui, H .

COORDINATION CHEMISTRY REVIEWS, 2002, 226 (1-2) :187-198

[24] Current state for the development of metallopharmaceutics and anti-diabetic metal complexes [J].

Sakurai, Hiromu ;

Yoshikawa, Yutaka ;

Yasui, Hiroyuki .

CHEMICAL SOCIETY REVIEWS, 2008, 37 (11) :2383-2392

[25] Vanadium salts as insulin substitutes: Mechanisms of action, a scientific and therapeutic tool in diabetes mellitus research [J].

Sekar, N ;

Li, JP ;

Shechter, Y .

CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1996, 31 (5-6) :339-359

[26] INSULIN-LIKE STIMULATION OF GLUCOSE-OXIDATION IN RAT ADIPOCYTES BY VANADYL (IV) IONS [J].

SHECHTER, Y ;

KARLISH, SJD .

NATURE, 1980, 284 (5756) :556-558

[27] Adipogenic action of vanadium: a new dimension in treating diabetes [J].

Shukla, Ruchi ;

Bhonde, Ramesh R. .

BIOMETALS, 2008, 21 (02) :205-210

[28] Chloro-substituted dipicolinate vanadium complexes: Synthesis, solution, solid-state, and insulin-enhancing properties [J].

Smee, Jason J. ;

Epps, Jason A. ;

Ooms, Kristopher ;

Bolte, Stephanie E. ;

Polenova, Tatyana ;

Baruah, Bharat ;

Yang, Luqin ;

Ding, Wenjun ;

Li, Ming ;

Willsky, Gail R. ;

la Cour, Agnete ;

Anderson, Oren P. ;

Crans, Debbie C. .

JOURNAL OF INORGANIC BIOCHEMISTRY, 2009, 103 (04) :575-584

[29] Anti-diabetic and toxic effects of vanadium compounds [J].

Srivastava, AK .

MOLECULAR AND CELLULAR BIOCHEMISTRY, 2000, 206 (1-2) :177-182

[30] Vanadyl sulfate, taurine, and combined vanadyl sulfate and taurine treatments in diabetic rats: Effects on the oxidative and antioxidative systems [J].

Tas, Sibel ;

Sarandol, Emre ;

Ayvalik, Sedef Ziyanok ;

Serdar, Zehra ;

Dirican, Melahat .

ARCHIVES OF MEDICAL RESEARCH, 2007, 38 (03) :276-283

← 1 2 3 4 →